Can I see the history of Medicare Part D retail drug prices or how drug prices have changed over time?
Yes. We show the
average
negotiated retail drug price in the far right column of our Q1Rx.com
Drug
Finder comparison chart - and when you click on the retail price we show more information about drug costs - including the historical retail prices.
Remember: We show the average negotiated retail drug
prices - and you will find that the actual retail prices can vary pharmacy-to-pharmacy (so CVS retail prices may not be the same as prices at WalMart or Walgreens) and prices can change week-to-week. Also, please note that the average negotiated retail drug price can vary
state-to-state as you travel with your Medicare Part D plan.
Here is an example of our Q1Rx.com Drug Finder showing how the retail price of a popular generic medication can vary between Medicare Part D plans (the estimated cost using a Drug Discount Card is shown at the top of the Q1Rx table).
Seeing how retail drug prices can change over time.
To see how a retail price can change with a certain Medicare Part D
plan, you can click on the average negotiated retail drug price (in this
example, the Cigna-HealthSpring price of
$6.60) to view the pricing history for a particular plan and drug.
The same average retail drug pricing information is also available when using our
Formulary
Browser and clicking on the 30-day supply or 90-day supply cost-sharing figures.
See the
2021 Rosuvastatin data and see the
current Rosuvastatin data.
Question: Why are retail drug prices important when you have Medicare drug coverage?
Higher retail drug costs can mean that you pay more for your drug
coverage - and higher retail drug prices mean that you move faster
through the phases of your Medicare drug coverage.
- Retail drug costs determine the time you spend in the Initial Deductible.
If your
Medicare prescription drug plan has an initial deductible, retail drug prices will affect how long you stay in the
deductible.
- Retail drug costs determine the time you spend in the Initial Coverage Phase before reaching the Coverage Gap.
You receive initial coverage until you reach your plan's Initial Coverage Limit
(ICL) and your plan's negotiated retail cost for your medication is
used to determined when you reach your ICL. For example, if you
purchase a medication with a retail cost of $500 and you have a co-pay
of $60, the $500 retail value is counted toward meeting your Initial
Coverage Limit - and when you exceed the Initial Coverage Limit, you
enter the Coverage Gap or Donut Hole - and pay 75% of the plan's retail price.
- Retail drug costs can determine what you will pay in the Initial Coverage phase.
If your Medicare prescription drug plan uses co-insurance cost
sharing, then you will pay a percentage of the retail drug costs for
your formulary drugs. For example, if you pay a 25% co-insurance for a
medication that has a negotiated retail drug
price of $100, your cost-sharing is $25 - and the $100 retail cost
is counted toward the Initial Coverage Limit. If the retail drug price
increases to $200 during the plan year, you will pay $50 for the same
medication - even though the coverage cost was $25 for the same drug
back when you enrolled in the plan.
- Retail drug costs dictate what you pay in the Donut Hole.
Once you are in the Donut Hole or Coverage Gap, you will receive the 75% Donut Hole discount for all formulary drugs. In other words, you pay 25% of the retail cost for your formulary prescriptions.
- Retail drug prices determine what you pay in the Catastrophic Coverage phase.
If you have high out-of-pocket spending, you may enter the Catastrophic Coverage phase and your cost-sharing while in the Catastrophic
Coverage phase (after leaving the Donut Hole) can vary
depending on the retail price of your drugs. For example, in 2021, you
pay the greater of $3.70 or 5% of your plan’s
negotiated retail drug price for generics or the higher of $9.20 or
5% of the retail cost of your brand-name drugs.
In short, with higher retail drug price your out-of-pocket cost can be
different than what you predicted when you chose your Medicare Part D
drug plan last fall - meaning, you may no longer be enrolled in the most
economic Medicare prescription drug plan.
See the
2021 Rosuvastatin data and see the
current Rosuvastatin data.